{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:00:10Z","timestamp":1790532010067,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL113574"],"award-info":[{"award-number":["HL113574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL114457"],"award-info":[{"award-number":["HL114457"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL136969"],"award-info":[{"award-number":["HL136969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL137990"],"award-info":[{"award-number":["HL137990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.neulet.2019.134483","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:50:32Z","timestamp":1567684232000},"page":"134483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Differential role of adenosine signaling cascade in acute and chronic pain"],"prefix":"10.1016","volume":"712","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-4509","authenticated-orcid":false,"given":"Morayo G.","family":"Adebiyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-8102","authenticated-orcid":false,"given":"Jeanne","family":"Manalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney E.","family":"Kellems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.134483_bib0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neulet.2019.134483_bib0010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/17512433.2016.1204231","article-title":"Transmission pathways and mediators as the basis for clinical pharmacology of pain","volume":"9","author":"Kirkpatrick","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134483_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/758181","article-title":"The role of purinergic receptors in cancer-induced bone pain","volume":"2012","author":"Falk","year":"2012","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.neulet.2019.134483_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.apha.2015.09.001","article-title":"Purinergic mechanisms and pain","volume":"75","author":"Burnstock","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134483_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11302-005-6210-4","article-title":"ATP receptors in pain sensation: involvement of spinal microglia and P2X(4) receptors","volume":"1","author":"Inoue","year":"2005","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neulet.2019.134483_bib0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134483_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11302-018-9629-0","article-title":"Role of purinergic receptors in the Alzheimer\u2019s disease","volume":"14","author":"Cieslak","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neulet.2019.134483_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fphar.2018.00325","article-title":"Purinergic receptors in neurological diseases with motor symptoms: targets for therapy","volume":"9","author":"Oliveira-Giacomelli","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134483_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1213\/01.ane.0000267260.00384.d9","article-title":"Adenosine as a non-opioid analgesic in the perioperative setting","volume":"105","author":"Gan","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neulet.2019.134483_bib0050","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1152\/japplphysiol.00350.2015","article-title":"Beneficial and detrimental role of adenosine signaling in diseases and therapy","volume":"119","author":"Liu","year":"2015","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.neulet.2019.134483_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2004.11.034","article-title":"Adenosine contributes to mu-opioid synaptic inhibition in rat substantia gelatinosa in vitro","volume":"376","author":"Ackley","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134483_bib0060","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1523\/JNEUROSCI.5324-09.2010","article-title":"Ecto-5\u2032-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits","volume":"30","author":"Sowa","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134483_bib0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-8069-6-20","article-title":"Recombinant ecto-5\u2032-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation","volume":"6","author":"Sowa","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neulet.2019.134483_bib0070","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1074\/jbc.273.9.5093","article-title":"Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency","volume":"273","author":"Blackburn","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134483_bib0075","first-page":"93","article-title":"Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA)","volume":"4","author":"Hershfield","year":"1993","journal-title":"Immunodeficiency"},{"key":"10.1016\/j.neulet.2019.134483_bib0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.celrep.2016.05.080","article-title":"Sustained elevated adenosine via ADORA2B promotes chronic pain through neuro-immune interaction","volume":"16","author":"Hu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neulet.2019.134483_bib0085","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0028-3908(00)00207-0","article-title":"Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system","volume":"40","author":"Jennings","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2019.134483_bib0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1113\/jphysiol.2002.038091","article-title":"Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1","volume":"548","author":"Ackley","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.neulet.2019.134483_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2005.08.017","article-title":"Localization of the NBMPR-sensitive equilibrative nucleoside transporter, ENT1, in the rat dorsal root ganglion and lumbar spinal cord","volume":"1059","author":"Governo","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.134483_bib0100","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2019.134483_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2019.134483_bib0110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1152\/japplphysiol.00155.2017","article-title":"Erythrocyte purinergic signaling components underlie hypoxia adaptation","volume":"123","author":"Sun","year":"2017","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.neulet.2019.134483_bib0115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nn.2562","article-title":"Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture","volume":"13","author":"Goldman","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2019.134483_bib0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pain.2004.11.020","article-title":"Increased nociceptive response in mice lacking the adenosine A1 receptor","volume":"113","author":"Wu","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2019.134483_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2010.09.034","article-title":"Differential effects of adenosine A1 receptor on pain-related behavior in normal and nerve-injured rats","volume":"1361","author":"Gong","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.134483_bib0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/j.1532-2149.2013.00439.x","article-title":"Norisoboldine attenuates inflammatory pain via the adenosine A1 receptor","volume":"18","author":"Gao","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neulet.2019.134483_bib0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2005.03.026","article-title":"Pharmacokinetic\/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain","volume":"514","author":"Schaddelee","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134483_bib0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2008.07.012","article-title":"A 2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury","volume":"140","author":"Bura","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2019.134483_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(98)00216-X","article-title":"Expression of adenosine A2a receptor gene in rat dorsal root and autonomic ganglia","volume":"246","author":"Kaelin-Lang","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134483_bib0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neulet.2011.11.004","article-title":"Deletion of the adenosine A(2A) receptor in mice enhances spinal cord neurochemical responses to an inflammatory nociceptive stimulus","volume":"506","author":"Hussey","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134483_bib0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuroscience.2010.07.045","article-title":"Peripheral adenosine A2A receptors are involved in carrageenan-induced mechanical hyperalgesia in mice","volume":"170","author":"Li","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2019.134483_bib0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0304-3940(02)00524-4","article-title":"Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain","volume":"328","author":"Bastia","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134483_bib0165","first-page":"1501","article-title":"Phrenic motor neuron adenosine 2A receptors elicit phrenic motor facilitation","volume":"596","author":"Seven","year":"2018","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.neulet.2019.134483_bib0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/jpet.103.056036","article-title":"Antinociceptive effects of novel A2B adenosine receptor antagonists","volume":"308","author":"Abo-Salem","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.134483_bib0175","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.neulet.2019.134483_bib0180","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1152\/physrev.00011.2002","article-title":"Beyond neurons: evidence that immune and glial cells contribute to pathological pain states","volume":"82","author":"Watkins","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neulet.2019.134483_bib0185","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1096\/fj.201700219R","article-title":"HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis","volume":"31","author":"Philip","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2019.134483_bib0190","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1523\/JNEUROSCI.4495-14.2015","article-title":"Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain","volume":"35","author":"Ford","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134483_bib0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/awu330","article-title":"Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states","volume":"138","author":"Little","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2019.134483_bib0200","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25263","article-title":"Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease","author":"Xu","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.neulet.2019.134483_bib0205","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1172\/JCI64578","article-title":"Extracellular hemin crisis triggers acute chest syndrome in sickle mice","volume":"123","author":"Ghosh","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134483_bib0210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ajh.23575","article-title":"Neuropathy, neuropathic pain, and sickle cell disease","volume":"88","author":"Ballas","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.neulet.2019.134483_bib0215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.neulet.2019.134483_bib0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1743-6109.2011.02287.x","article-title":"Priapism in sickle-cell disease: a hematologist\u2019s perspective","volume":"9","author":"Kato","year":"2012","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.neulet.2019.134483_bib0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nm.2280","article-title":"Detrimental effects of adenosine signaling in sickle cell disease","volume":"17","author":"Zhang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2019.134483_bib0230","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/bloodadvances.2018015784","article-title":"Elevated ecto-5\u2032-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease","volume":"2","author":"Liu","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.neulet.2019.134483_bib0235","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI74604","article-title":"Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression","volume":"124","author":"Zhang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134483_bib0240","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2014-08-595751","article-title":"Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity","volume":"125","author":"Sun","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.neulet.2019.134483_bib0245","doi-asserted-by":"crossref","first-page":"15281","DOI":"10.1038\/s41598-017-13667-8","article-title":"Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease","volume":"7","author":"Sun","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2019.134483_bib0250","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1152\/jn.00120.2006","article-title":"Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons","volume":"96","author":"Zhang","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neulet.2019.134483_bib0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2400","article-title":"The alliance of sphingosine-1-phosphate and its receptors in immunity","volume":"8","author":"Rivera","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neulet.2019.134483_bib0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2012.03.019","article-title":"Knockdown of the sphingosine-1-phosphate receptor S1PR1 reduces pain behaviors induced by local inflammation of the rat sensory ganglion","volume":"515","author":"Xie","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134483_bib0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12974-015-0286-8","article-title":"Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and\/or 3","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2019.134483_bib0270","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/j.pain.0000000000000965","article-title":"Targeting the S1P\/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation","volume":"158","author":"Grenald","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2019.134483_bib0275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2011.05.018","article-title":"Sphingosine-1-phosphate acting via the S1P(1) receptor is a downstream signaling pathway in ceramide-induced hyperalgesia","volume":"499","author":"Doyle","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134483_bib0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017268","article-title":"Genetic evidence for involvement of neuronally expressed S1P(1) receptor in nociceptor sensitization and inflammatory pain","volume":"6","author":"Mair","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134483_bib0285","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1523\/JNEUROSCI.4479-12.2013","article-title":"Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor","volume":"33","author":"Camprubi-Robles","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134483_bib0290","article-title":"Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease","author":"Zhao","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2019.134483_bib0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases","volume":"113","author":"O\u2019Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2019.134483_bib0300","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134483_bib0305","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/j.pain.0000000000001106","article-title":"Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn","volume":"159","author":"Doolen","year":"2018","journal-title":"Pain"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:30:37Z","timestamp":1759609837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019305865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":61,"alternative-id":["S0304394019305865"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134483","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential role of adenosine signaling cascade in acute and chronic pain","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134483"}}